tag:blogger.com,1999:blog-6377401824680246858.post7394170571441989614..comments2024-03-05T15:49:16.751+00:00Comments on The SPC blog: Actavis v Boehringer: more questions for the CJEUroberthttp://www.blogger.com/profile/03575489215896576032noreply@blogger.comBlogger3125tag:blogger.com,1999:blog-6377401824680246858.post-86594158467666367462013-10-25T15:24:55.885+01:002013-10-25T15:24:55.885+01:00Boehringer was allowed to limit its patent in Germ...Boehringer was allowed to limit its patent in Germany to explicitly mention the combination product with the second SPC.<br /><br />Now it will be interesting to see whether the SPC for Telmisartan+HCT will be upheld in Germany following this.<br /><br />See also: <a rel="nofollow">http://kluwerpatentblog.com/2013/10/10/medeva-and-the-limitation-of-composition-claims/</a>Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-6377401824680246858.post-13583730032098331172013-10-23T16:15:07.184+01:002013-10-23T16:15:07.184+01:00Following the post on Tuesday, 17 September 2013 &...Following the post on Tuesday, 17 September 2013 "One SPC per patent again -- this time in the Netherlands", then surely this SPC is invalid, at least as far as the Dutch courts are concerned? Or am I missing something?Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-6377401824680246858.post-19398824662340912912013-10-19T15:19:02.939+01:002013-10-19T15:19:02.939+01:00There is one point that I do not understand:the se...There is one point that I do not understand:the second SPC has been granted on 01/13/2005 and expires on 01/30/2017.It means 12 years duration. Art.13.2 of regulation sets a limit of 5 years (amended patent valid till 01/30/2012, right, so it s within, but overall maximum protection of 15 years). Original Patent expired in 2002, so, on the basis of an amendment to this original patent, you can get a kind of 15 additional years protection of the combination (which was also protected by the original patent which expired in 2002...). Clever ever*greening where IPO recommended to the applicant to amend its original patent...Anonymousnoreply@blogger.com